Figure 1From: Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone MRI of GCT pre and post zoledronic acid treatment. Axial T2- weighted (fat-suppressed) MRI of (a) pre and (b) 5 year post-zoledronic acid treatment of Case 12, an enlarging sacral/pelvic GCTB which shows stabilisation of tumour size. Following treatment there is some evidence of infilling of the lytic tumour (arrowed) following zoledronic acid treatment.Back to article page